Teva study reveals diagnostic gap in tardive dyskinesia among young adults
Go back to Teva study reveals diagnostic gap in tardive dyskinesia among young adults| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.14 +0.94 (2.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.26 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 2,967,856 | |||||
